Pulmatrix GAAP EPS of -$0.42

2 hours ago 1

Pulmatrix press release (NASDAQ:PULM): Q2 GAAP EPS of -$0.42.
The Company's total cash and cash equivalents balance as of June 30, 2025, was $5.8 million. The Company anticipates that its cash position, based on operational efficiencies and prioritization of spending, is sufficient to fund its operations at least through the anticipated closing of the proposed Merger with Cullgen.

Recommended For You